SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
      Showing session: reset
						
            NONCOMMUNICABLE DISEASES IN TREATED HIV
           
      
	
		- Sort by:
 
				
	
	
 
    
          
        | 
            
              << first | < prev
    
    page: 
    
    of 1 
         | 
        
    
    records per page:
    
    
    
     next > | last >>    
                  
         | 
      
      
        |        pages:  1   
         | 
        
          
    
    presentations: 
    1 to 
    8 of 
    8 
    
         | 
      
     
    
    
      
      
      
      
        BREAKING BONES IS BAD: INCIDENT FRACTURE AND MORTALITY IN THE HIV OUTPATIENT STUDY   (ABSTRACT
        30)
        
              Linda Ann Battalora
              Colorado School of Mines, Golden, CO, USA
  
       
      
      
      
      
        COPD AND THE RISK FOR MYOCARDIAL INFARCTION BY TYPE IN PEOPLE LIVING WITH HIV   (ABSTRACT
        31)
        
              Kristina Crothers
              University of Washington, Seattle, WA, USA
  
       
      
      
      
      
        SUDDEN CARDIAC DEATH AMONG HIV-INFECTED AND -UNINFECTED VETERANS   (ABSTRACT
        32)
        
              Matthew Freiberg
              Vanderbilt University School of Medicine, Nashville, TN, USA
  
       
      
      
      
      
        HIV POST SCD STUDY: 80% HIGHER RATE OF AUTOPSY-DEFINED SUDDEN ARRHYTHMIC DEATH IN HIV   (ABSTRACT
        33)
        
              Zian H. Tseng
              UCSF, San Francisco, CA, USA
  
       
      
      
      
      
        CABOTEGRAVIR IS NOT ASSOCIATED WITH WEIGHT GAIN IN HIV-NEGATIVE INDIVIDUALS: HPTN 077   (ABSTRACT
        34)
        
              Raphael J. Landovitz
              University of California Los Angeles, Los Angeles, CA, USA
  
       
      
      
      
      
        ASSESSING THE PROBIOTIC EFFECT IN TREATED HIV: RESULTS OF ACTG A5350   (ABSTRACT
        35)
        
              Edgar Turner Overton
              University of Alabama, Birmingham, AL, USA
  
       
      
      
      
      
        FACTOR X INHIBITION REDUCES COAGULATION BUT NOT INFLAMMATION IN PERSONS WITH HIV   (ABSTRACT
        36)
        
              Jason V Baker
              Hennepin Healthcare Research Institute (U of MN), Minneapolis, MN, USA
  
       
      
      
      
      
        SAFETY, TOLERABILITY AND IMMUNOLOGIC ACTIVITY OF RUXOLITINIB ADDED TO SUPPRESSIVE ART   (ABSTRACT
        37)
        
              Vincent C. Marconi
              School of Medicine, Emory University, Atlanta, GA, USA
  
       
    
          
        | 
            
              << first | < prev
    
    page: 
    
    of 1 
         | 
        
    
    records per page:
    
    
    
     next > | last >>    
                  
         | 
      
      
        |        pages:  1   
         | 
        
          
    
    presentations: 
    1 to 
    8 of 
    8 
    
         |